Tivic Receives Request from Ukraine for Entolimod Stockpiling

Ukrainian Ministry of Health seeks information on strategic supply of Tivic's radiation countermeasure drug.

Mar. 31, 2026 at 2:00pm

Got story updates? Submit your updates here. ›

An extreme close-up X-ray photograph revealing the intricate molecular structure of a radiation countermeasure drug, conceptually illustrating its potential importance for emergency preparedness.A radiation countermeasure drug could be a critical asset for countries facing potential nuclear threats.San Antonio Today

Tivic Health, a San Antonio-based biomedical company, has received a formal request for information from the Ukrainian Ministry of Health regarding the strategic stockpiling of Entolimod, Tivic's radiation countermeasure drug. The request comes as Ukraine continues to bolster its preparedness measures in the face of ongoing regional tensions.

Why it matters

Entolimod is a promising treatment that can help mitigate the effects of radiation exposure, making it a valuable asset for countries like Ukraine that face potential nuclear threats. Tivic's ability to supply this critical drug could play a key role in Ukraine's emergency response planning.

The details

The request from the Ukrainian Ministry of Health seeks detailed information from Tivic about the company's manufacturing capabilities, supply chain, and distribution channels for Entolimod. This suggests Ukraine is actively exploring options to build a strategic stockpile of the radiation countermeasure drug.

  • Tivic received the formal request from the Ukrainian Ministry of Health on March 29, 2026.

The players

Tivic Health

A San Antonio-based biomedical company that develops Entolimod, a radiation countermeasure drug.

Ukrainian Ministry of Health

The government agency in Ukraine responsible for public health and emergency preparedness measures.

Got photos? Submit your photos here. ›

What’s next

Tivic plans to provide a comprehensive response to the Ukrainian Ministry of Health's request in the coming weeks, outlining its capabilities to potentially supply Entolimod for strategic stockpiling.

The takeaway

This request from Ukraine highlights the growing global demand for effective radiation countermeasure treatments, and Tivic's Entolimod could play a vital role in strengthening Ukraine's emergency response capabilities.